Maynard Um
-
-
-
-
-
-
-
Vaxart secures $25 million equity financing deal with Lincoln Park
-
-
-
-
-
-
-
Vaxart (VXRT) Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology
-
-
-
-
-
-
-
Vaxart (VXRT) Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate
-
-
-
-
-
-
-
Vaxart (VXRT) Tops Q3 EPS by 4c
-
-
-
-
-
-
-
Vaxart (VXRT) 30-day option implied volatility above 100
-
-
466,314 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


